Business Wire

MI-LINEAGE-LOGISTICS

28.10.2021 15:02:07 CEST | Business Wire | Press release

Share
Lineage Logistics Launches Nonprofit Lineage Foundation for Good

Lineage Logistics, LLC (“Lineage” or the “Company”), the world’s largest and most innovative temperature-controlled industrial REIT and logistics solutions provider, today announced the launch of the Lineage Foundation for Good (the “Foundation”), an independent nonprofit aimed at reducing food waste and fighting food insecurity to support the global communities where over 21,000 of Lineage’s team members live and work.

According to the Food and Agriculture Organization of the United Nations (FAO) and the UN Environment Programme (UNEP), an estimated one-third of all food produced globally for human consumption is wasted. Of that number, over 40% is attributed to wasted food in the U.S., which equates to roughly 1.3 billion tons of food and 7% of greenhouse gas emissions. By comparison, 30% of temperature-controlled food products in the U.S. and nearly 10% globally travel through Lineage’s warehouse network. As a result, the Company’s unique visibility into its customers’ inventories and the greater food supply chain allows Lineage to proactively identify and facilitate donations of product that might have otherwise gone to waste.

“Given our role in the food supply chain, Lineage recognized that we are in a unique position to leverage our global network of resources to make an impact in the communities where we live and work,” said Greg Lehmkuhl, Lineage’s President and CEO. “The Lineage Foundation for Good creates a real-time link to redirect for donation quality products from food producers and manufacturers that might otherwise go to waste. The Foundation will further fuel our purpose to help feed the world and reimagine the global food ecosystem by limiting its environmental impact through food waste.”

The Foundation, which was created by a $3 million gift from Lineage, will leverage the Company’s access, influence, experience, and expertise in areas like logistics, automated warehousing, cold storage, data science, and distribution to address and improve the global food supply chain’s carbon imprint, reimagine industry processes that have historically led to food waste, and quickly redirect food to be distributed to communities around the world. Darcee Scavone, Lineage’s Vice President of Talent, Culture and Community Engagement, will oversee coordination between the Company and the Foundation and serve as the point of contact internally.

“Heightened by the COVID-19 pandemic, food insecurity is a pressing issue that millions around the globe are facing. Now, more than ever, people need access to quality food, and we are proud to be part of the solution to bring it to them,” said Darcee Scavone. “We have long partnered with the Global FoodBanking Network and Feeding America® and are building on this commitment by putting a vehicle – the connective tissue – in place to facilitate both food and financial donations, as well as promote volunteerism, globally.”

In addition to supporting Lineage’s philanthropic efforts, the Foundation will also support initiatives and organizations that align to its mission and work towards innovative and sustainable solutions to help reduce waste and fight food insecurity.

“Efforts to alleviate hunger and reduce food loss and waste are interlinked and vitally important,” said Lisa Moon, CEO and president of The Global FoodBanking Network. “Lineage Logistics has already demonstrated its commitment to addressing these issues by partnering with food banks globally, and the creation of the Lineage Foundation for Good further underscores this commitment. GFN is looking forward to the increased impact that will be possible as we work together to support community-driven solutions to address food insecurity worldwide.”

“America has more than enough food to feed everyone. But each year, billions of pounds of perfectly good food go to waste,” said Casey Marsh, Chief Development Officer at Feeding America. “Feeding America is the country's largest food rescue organization, and we applaud Lineage Logistics in their efforts to assure food isn’t wasted and gets to food banks serving our neighbors.”

In addition to partnering with the Global FoodBanking Network and Feeding America, the Foundation also works with similarly minded regional and local organizations.

The Foundation operates as a public charity under its own leadership and organizational structure, including a Board of Directors that will oversee all activities and business affairs. The Foundation also plans to accept multi-year annual contributions from Lineage, as well as gifts and direct donations from other individuals and organizations whose work is aligned with its mission to fight food insecurity, reduce food waste, and feed the world.

For more information and updates, please visit Lineage Foundation for Good .

About Lineage Foundation for Good

The Lineage Foundation for Good (the “Foundation”) is the independent philanthropic arm of Lineage Logistics, LLC (“Lineage”). The Foundation leverages the unique access, influence, experience, and expertise of Lineage, one of the world’s largest temperature-controlled logistics solutions providers, and its customers and partners to reduce food waste and fight food insecurity – a need that was accelerated by the practical challenges of getting quality food to those in need during the COVID-19 pandemic. Central to the Foundation’s mission is to develop a dynamic, real-time, and global link between those who commercially produce our food and the individuals, families, and communities who need it most. The Foundation creates a system in which food products, including those that might have otherwise gone to waste, can be quickly and easily steered to food pantries and other non-profits combatting food insecurity around the world. The Foundation supports various philanthropic initiatives that have an impact in the communities in which we live and work, and is proud to partner with Feeding America, the Global FoodBanking Network, and other organizations to expand its reach, maximize its impact, and help feed the world.

About Lineage Logistics

Lineage Logistics is the world’s largest temperature-controlled industrial REIT and logistics solutions provider. It has a global network of over 400 strategically located facilities totaling over 2 billion cubic feet of capacity which spans 15 countries across North America, Europe and Asia-Pacific. Lineage’s industry-leading expertise in end-to-end logistical solutions, its unrivaled real estate network, and development and deployment of innovative technology help increase distribution efficiency, advance sustainability, minimize supply chain waste, and most importantly, as a Visionary Partner of Feeding America, help feed the world. In recognition of the company’s leading innovations and sustainability initiatives, Lineage was listed as No. 17 in the 2021 CNBC Disruptor 50 list, the No 1. Data Science company, and 23rd overall, on Fast Company’s 2019 list of The World’s Most Innovative Companies, in addition to being included on Fortune’s Change The World list in 2020.

Link:

ClickThru

Social Media:

https://www.facebook.com/lineagelogistics/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IEO and Laife Reply Join Forces to Digitalise the Biobank Through Artificial Intelligence10.2.2026 10:00:00 CET | Press release

The two partners launch “Bianca”, the first large-scale digitalisation initiative in Italy focused on histopathological samples, aimed at training AI algorithms to support pathologists’ diagnostic activities. The Pathology Division of the European Institute of Oncology (IEO) and Laife Reply, the Reply Group company specialised in AI and Big Data solutions for the healthcare sector, have entered into a collaboration to develop Bianca, the first project in Italy aimed at creating an AI-based digital biobank designed as an integral part of clinical diagnostic practice. The initiative is part of a broader technological innovation journey that structurally integrates research and development into routine diagnostic processes in pathology, transforming the traditional histopathological sample workflow into an end-to-end digital ecosystem. The complete digitalisation of histopathological and molecular diagnostic workflows aims to make analysis more efficient, scalable and reproducible, laying

OPEX® Corporation Introduces the Velo™ Series of Premium Desktop and High Production Document Scanners10.2.2026 10:00:00 CET | Press release

OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, has announced the launch of its Velo™ Series powered by InoTec, a new class of premium desktop and free standing high production scanners. The OPEX Velo scanners are engineered to deliver exceptional performance, reliability and image quality and offer industry-standard TWAIN/ISIS connectivity to help simplify deployment into existing capture environments. These state-of-the-art scanners are ideal for service bureaus, government agencies, healthcare providers and enterprise capture operations. “The Velo Series powered by InoTec introduces an entirely new class of scanners to the OPEX portfolio, expanding the options available to both our current customers and organizations considering OPEX for the first time,” said Dann Worrell, President, Document and Mail Automation, OPEX. “By broadening our offerings, we can better align the right solution with

New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval10.2.2026 10:00:00 CET | Press release

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations. Equipped with ZOLL’s innovative Real BVM Help® and exclusive Real CPR Help® technology, Zenix gives healthcare pro

Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution10.2.2026 10:00:00 CET | Press release

Expereo is redefining what’s possible for global enterprises at CiscoLive Amsterdam with the launch of its enhanced Digital Case Management (DCM) capability in expereoOne. As the world-leading managed Network as a Service (NaaS) provider, Expereo is putting customers firmly in control - slashing resolution times, cutting through operational noise and ensuring everyone is aligned every step of the way. With DCM, service issues are no longer bottlenecks: instead, enterprises experience swift, transparent outcomes, with every stakeholder empowered through a single, real-time view of progress. DCM is designed around a simple objective: enable enterprises to resolve issues faster, with greater clarity and full control, through a fully digital, software-first workflow inside expereoOne. Customers can create, manage and track cases end-to-end within a single platform, ensuring predictable, consistent and aligned service experiences across their global network footprint. Unified, digital-first

U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 09:15:00 CET | Press release

This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment OptionsOveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and Address the Underlying Orexin Deficiency that Causes Narcolepsy Type 1The Prescription Drug User Fee Act (PDUFA) Target Action Date is the Third Quarter of this Calendar Year Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye